Aspiriant LLC Increases Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Aspiriant LLC boosted its stake in The Procter & Gamble Company (NYSE:PG) by 8.2% in the fourth quarter, Holdings Channel reports. The fund owned 33,076 shares of the company’s stock after buying an additional 2,510 shares during the quarter. Aspiriant LLC’s holdings in Procter & Gamble were worth $5,545,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in PG. Fiera Capital Corp lifted its position in shares of Procter & Gamble by 1,135.1% during the second quarter. Fiera Capital Corp now owns 20,688 shares of the company’s stock worth $3,412,000 after purchasing an additional 19,013 shares during the last quarter. Wescott Financial Advisory Group LLC raised its position in shares of Procter & Gamble by 10.1% during the 2nd quarter. Wescott Financial Advisory Group LLC now owns 23,146 shares of the company’s stock valued at $3,817,000 after acquiring an additional 2,114 shares in the last quarter. Fred Alger Management LLC increased its stake in Procter & Gamble by 4.7% during the second quarter. Fred Alger Management LLC now owns 67,580 shares of the company’s stock valued at $11,145,000 after purchasing an additional 3,006 shares during the last quarter. Trinity Legacy Partners LLC lifted its position in shares of Procter & Gamble by 1.2% in the 2nd quarter. Trinity Legacy Partners LLC now owns 33,219 shares of the company’s stock worth $5,478,000 after buying an additional 409 shares during the last quarter. Finally, Prairie Wealth Advisors Inc. grew its position in shares of Procter & Gamble by 3.0% during the 2nd quarter. Prairie Wealth Advisors Inc. now owns 3,453 shares of the company’s stock valued at $569,000 after buying an additional 99 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Price Performance

NYSE PG opened at $164.57 on Thursday. The firm has a market capitalization of $387.56 billion, a price-to-earnings ratio of 28.37, a price-to-earnings-growth ratio of 3.63 and a beta of 0.45. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The company has a 50 day simple moving average of $169.01 and a 200-day simple moving average of $169.41. The Procter & Gamble Company has a 52-week low of $152.06 and a 52-week high of $180.43.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Wednesday, January 22nd. The company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.86 by $0.02. The business had revenue of $21.88 billion for the quarter, compared to the consensus estimate of $21,657,595.49 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. Procter & Gamble’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.84 earnings per share. Equities research analysts predict that The Procter & Gamble Company will post 6.92 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be paid a $1.0065 dividend. The ex-dividend date is Friday, January 24th. This represents a $4.03 annualized dividend and a dividend yield of 2.45%. Procter & Gamble’s payout ratio is 69.48%.

Analyst Ratings Changes

PG has been the topic of a number of recent research reports. DA Davidson reiterated a “buy” rating and issued a $209.00 target price on shares of Procter & Gamble in a research note on Friday, December 27th. UBS Group reduced their price target on shares of Procter & Gamble from $196.00 to $189.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. Stifel Nicolaus decreased their target price on Procter & Gamble from $167.00 to $161.00 and set a “hold” rating for the company in a research note on Friday, January 17th. Wells Fargo & Company cut their price target on shares of Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $164.00 price objective on shares of Procter & Gamble in a research note on Monday, October 21st. Eight equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus price target of $179.65.

Insider Buying and Selling

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the transaction, the insider now directly owns 11,595 shares of the company’s stock, valued at $2,002,804.35. This represents a 52.47 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the sale, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at $7,189,463.68. This represents a 54.48 % decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is currently owned by corporate insiders.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.